Influence of Hepatic Cells on Allogeneic Islet Transplantation in Rats Without Immunosuppressive Drugs

With the hypothesis of a possible helpful effect of the liver on islets transplanted into it, we have performed experiments that suggest some effect of hepatic cells for islet tolerance. We have studied 6 groups of Wistar rats made diabetic with streptozotocin and transplanted in sham conditions and with a mixture of islets and hepatic cells (allo-co-transplantation ) in several conditions, all of them via the portal vein, and observed them over 30 days. Groups were as follows: Group A had a sham transplantation with saline. Group B was transplanted with hepatic cells alone. Group C was transplanted with islets alone without hepatic cells. Group D was co-transplanted with cultured islets and fresh hepatic cells (ratio 1:100). Group E was as group D with a ratio of 1:200. Group F also had co-transplantation, but after co-culture of islets and hepatic cells for 24 hours. Results show reversion of diabetes in group D for 4 - 5 days, and thereafter, a fall of blood glucose during the period observed. The effect was less marked in group F after co-culture of islets and hepatic cells. Paradoxically, when the ratio of islets and hepatic cell were 1:200, the results were not so good. These results suggest that hepatic cells have some helpful effect on islets when co- transplanted in the liver via the portal vein. More studies are needed to clarify if this effect can be related to some hepatic cell subpopulation; also if the effect is a membrane one, cell-to-cell contact, or through some secreted product.

Key words:

Islet - Allografts - Cotransplantation - Hepatocytes - Rats

References

• 1 Bretzel R G, Brandhorst D, Brandhorst H, Eckard M, Ernst W, Friemann S, Rau W, Weimar B, Rauber K, Hering B J, Brendel M D. Improved survival of intraportal pancreatic islet cell allograft in patients with type-1 diabetes mellitus by refined peritransplant management.  J Mol Med. 1999;  77 140-143
• 2 Selawry H, Fojacop R, Whittington K. Extended Survival of MHC-compatible islet grafts from diabetes-resistant donors in spontaneously diabetic BB/W rat.  Diabetes. 1987;  36 1061-1067
• 3 Selawry H .P, Cameron D F. Sertoli cell-enriched fractions in successful islet cell transplantation.  Cell Transpl. 1993;  2 123-129
• 4 Takeda Y, Gotoh M, Dono K, Nishihara M, Grochowiecki T, Kimura F, Yoshida T, Ohta Y, Ota H, Ohzato H, Umeshita K, Takeda T, Matsuura N, Sakon M, Kayagak N, Okumura K, Miyasaka M, Monden M. Protection of islet allografts transplanted together with Fas ligand expressing testicular allograft.  Diabetologia. 1998;  41 315-321
• 5 Korbutt G S, Elliott J F, Rajotte R V. Cotransplantation of allogenic islets with allogenic testicular cell aggregates allows long-term graft survival without systemic immunosuppression.  Diabetes. 1997;  46 317-322
• 6 Takeda Y, Gotoh M, Dono K, Grochowiecki T R, Kimura F, Okuyama M, Shimizu J, Nagano H, Umeshita K, Sakon M, Miyasaka M, Monden M. Acceptance of islet allografts transplanted with Fas Ligand expressing testicular allografts.  Transplant Proc. 1999;  31 24
• 7 Pearson T C, Alexander D Z, Hendrix R, Elwood E T, Linsley P S, Winn K J, Larsen C P. CTLA 4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoetic chimerism.  Transplantation. 1996;  7 997-1004
• 8 Markees T G, Appel M C, Noelle R J, Mordes J P, Greiner D L, Rossini A A. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.  Transpl Proc. 1996;  28 814-815
• 9 Li H, Inverardi L, Ricordi C. Graft-versus-host disease and function of intrahepatic islet grafts.  Transpl Proc. 1999;  31 639
• 10 Ricordi C, Flye M W, Lacy P E. Renal subcapsular transplantation of clusters of hepatocytes in conjunction with pancreatic islets.  Transplantation. 1988;  45 1148-1151
• 11 Legrelle M, Chapa O, Race J M, Mallegol S, Capron F, Altman J J. Islet and hepatocyte cotransplantation in rats.  Transpl Proc. 1993;  25 981
• 12 Lake S P, Anderson J, Chamberlain J, Gardner S J, Bell P RF, James R FL. Bovine serum albumin density isolation of rat pancreatic islets.  Transplantation. 1987;  43 805-808
• 13 Alvarez Gómez S, Soto Montenegro M L, Martínez Valenzuela B, Arranz Martin A, Martin-Scapa M C, Jara Albarrán A. Reversión de la Diabetes mediante el alotrasplante de islotes previo cultivo en RPMI 7 - 8 días frente a 1 - 2 dias.  Endocrinología. 1997;  44 119-121
• 14 Del Rio Valtierra R, Soto Montenegro M .L, Alvarez Gómez S, Martínez Valenzuela B, Arranz Martin A, Martín-Scapa M C, Jara Albarrán A. Estudio del número y pureza de islotes pancreáticos de rata en fresco y en cultivo, en mas de 500 aislamientos.  Av Diabetol. 1997;  13 139-143
• 15 Latif Z A, Noel T, Alejandro R. A simple method of staining fresh and cultured islets.  Transplantation. 1988;  45 827-830
• 16 Seglen P O. Preparation of isolated rat liver cells.  Methods Cell Biol. 1976;  13 29-83
• 17 Ricordi C, Hering B J, London N JM, Rajotte R V, Gray D WR, Sutherland D ER. Islet isolation assessment. In: Ricordi C (Ed) Pancreatic islet cell transplantation.  Austin; Landes 1992: 132-142
• 18 Denton M D, Magee C C, Sayegh M H. Immunosuppressive strategies in transplantation.  Lancet. 1999;  353 1083-1091
• 19 Schwartz R S. The new immunology. The end of immunosupressive drug therapy?.  New Engl J Med. 1999;  340 1754-1756
• 20 Lau H T, Yu M, Fontana A, Stoeckert C J Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.  Science. 1996;  273 09-112
• 21 Alexander V, Chervonsky A V, Wang Y, Wong F S, Visintin I, Flavell R A, Janeway CA J r, Matis L A. The role of Fas in autoimmune diabetes.  Cell. 1997;  89 17-24
• 22 Boros P, Miller C M. Hepatocyte growth factor: a multifunctional cytokine.  Lancet. 1995;  345 293-295
• 23 Vila M R, Nakamura T, Real F X. Hepatocyte growth factor is a potent mitogen for normal human pancreas cell in vitro.  Lab Invest. 1995;  73 409-418
• 24 Lefebvre V H, Otonkoski T, Ustinov J, Huotari M A, Pipeleers D G, Bouwens L. Culture of adult human islet preparations with hepatocyte growth factor and 804 G matrix is mitogenic for duct cells but not for beta-cells.  Diabetes. 1998;  47 134-137
• 25 Otonkoski T, Cirulli V, Beattie M, Mally M L, Soto G, Rubin J S, Hayek A. A role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic beta-cell growth.  Endocrinology. 1996;  137 3131-3139
• 26 Hayek A, Beattie G M, Cirulli V, Lopez A D, Ricordi C, Rubin J S. Growth factor/matrix-induced proliferation of human adult β-cells.  Diabetes. 1995;  44 1458-1460
• 27 Grisham J W. Cell types in rat liver cultures: their identification and isolation.  Mol Cell Bioch. 1983;  53/54 23-33
• 28 Fogli L, Morsiani E, Bertanti T, Eguchi S, Azzena G, Demetriou A A. Pancreatic beta-cell replication in streptozotocin-diabetic rats: the effect of liver compensatory growth on intraportally engrafted islets.  Pancreas. 1999;  19 304-309
• 29 Bottino R, Fernandez L A, Ricordi C, Lehmann R, Tsan M -F, Oliver R, Inverardi L. Effects of macrophage depletion on graft survival and microenvironment activation.  Diabetes. 1998;  47 316-323
• 30 Lenschow D J, Zeng Y, Thistlethwaite J R, Montag A, BradyW, Gibson M G, Linsley P S, Bluestone J A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig.  Science. 1992;  257 789-792
• 31 Liu C, Deng S, Yang Z, Kucher T, Guo F, Gelman A, Chen H, Naji A, Shaked A, Brayman K L. Local production of CTLA4-IG by adenoviral-mediated gene transfer to the pancreas induces permanent allograft survival and donor-specific tolerance.  Transplant Proc. 1999;  31 625-626
• 32 Tarumi K, Murakami M, Yagihashi A, Nakagawa I, Hirata K, Uede T. CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts.  Transplantation. 1999;  67 520-525
• 33 Feng S, Quictkel R, Hollister-Lock J, McLeod M, Bonner-Weir S, Mulligan R C, Weir G C. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig.  Transplantation. 1999;  67 1607-1613
• 34 Kita Y, Li X -K, Ohba M, Funeshima N, Enosawa S, Tamura A, Suzuki K, Amemiya H, Hayashi S, Kazui T, Suzuki S. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene.  Transplantation. 1999;  68 758-766